Long-term health management needs a scientific foundation that can be verified
In medicine, trust should not rest on concepts alone. It should be grounded in stable research capability, standardized preparation, and clear quality control. Backed by more than 20 years of Beike's scientific development, Beike Mlio connects foundational R&D, standardized preparation, and translational pathways into one support system.
Core R&D Platforms
Seven R&D platforms that support research and translation
The assessment, preparation, and translational capabilities behind Beike Mlio are supported by seven long-running research platforms working in concert.
Mesenchymal Stem Cell Research Platform
This platform focuses on the continued development of next-generation mesenchymal stem cell technologies, including work aimed at more targeted support strategies for complex conditions involving tissue damage and immune dysfunction.
Immune and Oncology Research Platform
Centered on immune activation and tumor-related research directions, this platform explores mechanisms tied to immune cell activation, maintenance, and longer-term translational potential.
Organoid Research Platform
The organoid platform supports disease modeling and ex vivo drug sensitivity research, helping generate more individualized insight by using organoid libraries and tumor subtype models.
Metabolomics Research Platform
Through the analysis of metabolic changes in body fluids, this platform studies the links between genes, lifestyle, and disease progression, supporting earlier pattern recognition in complex conditions.
Exosome Production and Purification Platform
This platform focuses on exosome production, purification, and application research, including ongoing work around higher-purity preparation and preclinical exploration in regenerative contexts.
iPSC and Transdifferentiation Platform
This platform develops induced pluripotent stem cell workflows and directed differentiation pathways, building foundational capability for future research in metabolic and neurodegenerative applications.
Biomaterials Research Platform
Focused on carrier materials that work alongside stem cell and exosome applications, this platform explores tissue-mimicking environments that may support repair, regeneration, and vascular recovery.
Expert Team
A core expert team shaped bytop academic and translational talent
The team includes academicians, nationally recognized researchers, doctoral supervisors, and industry experts, supported by a research organization of more than 740 people across science, process development, and translation.
Hu Junyuan
Chairman, Beike Biotechnology
PhD, University of Gothenburg / Chalmers University of Technology
A leader in translational biotechnology who has helped guide Beike from foundational research to international medical collaboration.
Lothar Willmitzer
Member, European and German Academies of Sciences
Founding Director, Max Planck Institute of Molecular Plant Physiology
A leading authority in metabolomics whose academic work informs the scientific direction of Beike's metabolomics platform.
Yu Yang
Researcher / Doctoral Supervisor
Peking University Third Hospital
Brings deep experience in translational work related to stem cells and regenerative medicine.
Jiang Wei
Professor
Wuhan University Institute of Medical Research
Focused on stem cell differentiation and epigenetics, contributing core academic support to the MSC platform.
Cai Cheguo
Professor / Vice President and Chief Scientist, Beike Biotechnology
Hangzhou Institute for Advanced Study, UCAS
Leads scientific direction-setting and technical breakthroughs across multiple Beike research pipelines.
Liang Xiao
Vice President, Beike Biotechnology
Senior Cell Preparation Engineer
Has played a key role in building Beike's standardized cell preparation and quality-control systems.
Li Yan
PhD
Max Planck Institute of Biochemistry
Contributes expertise across proteomics and metabolomics and supports platform standardization efforts.
Liao Yan
PhD
Sun Yat-sen University
Supports preclinical research tied to stem cells, tissue engineering, exosomes, and biomaterials.
Gao Yunfeng
PhD
Tianjin University of Science and Technology
Brings experience in bioactive component analysis and quality testing that supports Beike's product quality framework.
Zhang Mengna
PhD / Postdoctoral Researcher
Wuhan University / Hangzhou Institute for Advanced Study, UCAS
Contributes to cell biology and molecular mechanism research, especially in directed differentiation work within the iPSC platform.
Liu Chuntao
PhD
Sun Yat-sen University
Focuses on biomaterials and cell-carrier research, supporting the path from laboratory work toward preclinical validation.
Zheng Ran
PhD
Wuhan University
Works in epigenetics and stem cell differentiation control, contributing to next-generation MSC platform development.
Wu Bingyan
PhD
Guangzhou Institutes of Biomedicine and Health
Brings systematic experience in cell reprogramming and pluripotent stem cell research to the iPSC platform.
Clinical & Government Research
Clinical and public research collaboration withleading Chinese hospitals and institutions
Beike works with numerous top-tier hospitals and public research programs in China, helping build an evidence base for translational innovation through ongoing clinical and government-supported studies.
Qualifications & Patents
Standardization and quality control:the baseline for safety and consistency
In life science, technical capability must be supported by stable, traceable quality systems. Long-term trust depends on clear standards, ongoing verification, and disciplined control of process details.
System Certification · Integrated ISO Standards
System Certification · AABB International Accreditation (Seven Consecutive Cycles)
Invention Patents (Representative Patents, 207 Applications Filed)
Social Honors and Recognitions
From research to translation, results you can actually point to
The purpose of scientific work is not publication alone. It is to make medical thinking more actionable in real-world care. Explore More Research Details
0
More than 207 patent applications in the cell-related field
0+
Over 100 publications in international journals, including top-tier scientific outlets
0+
Participation in 70+ national-level research projects
0
More than 910 quality-control checkpoints across cell-related preparation workflows
Beike Mlio is built on a platform that continues to translate scientific work into more standardized service capability.
That includes progress in cell-related clinical pathways, translational preparation capability, and closer collaboration between research teams and real-world care settings.
Work with leading hospitals and public research institutions helps strengthen the evidence base behind program development and care design.
National standards participation, a 740+ person research team, standardized quality control, and structured data protection
Science matters, but so does the team that stays responsible over time
Research and laboratory capability provide the foundation. Long-term continuity comes from the people who interpret, coordinate, and follow through. See how the 1+N private doctor model connects diagnostics, technologies, and care planning into one ongoing system.